0.724
Adagio Medical Holdings Inc stock is traded at $0.724, with a volume of 79,100.
It is down -0.17% in the last 24 hours and down -31.05% over the past month.
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
See More
Previous Close:
$0.7252
Open:
$0.71
24h Volume:
79,100
Relative Volume:
0.64
Market Cap:
$16.08M
Revenue:
$137.00K
Net Income/Loss:
$-25.08M
P/E Ratio:
-0.4328
EPS:
-1.6729
Net Cash Flow:
$-19.39M
1W Performance:
-13.91%
1M Performance:
-31.05%
6M Performance:
-9.74%
1Y Performance:
-39.16%
Adagio Medical Holdings Inc Stock (ADGM) Company Profile
Name
Adagio Medical Holdings Inc
Sector
Industry
Phone
(949) 348-1188
Address
26051 MERIT CIRCLE, LAGUNA HILLS
Compare ADGM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings Inc
|
0.724 | 16.11M | 137.00K | -25.08M | -19.39M | -1.6729 |
|
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Adagio Medical Holdings Inc Stock (ADGM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-26 | Initiated | Piper Sandler | Overweight |
| Dec-02-25 | Initiated | Lake Street | Buy |
Adagio Medical Holdings Inc Stock (ADGM) Latest News
Adagio Medical’s vCLAS System Used to Treat Premature Ventricular Contractions - Medical Product Outsourcing
ADGM Q1 2026 Earnings: EPS Misses Estimates, Shares Slide 10.8%Revenue Inflection Point - newsline.com
Adagio Medical Holdings (ADGM) Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Ongoing Development CostsProfitability Analysis - newsline.com
Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia - BioSpace
Adagio Files PMA for Breakthrough Ventricular Ablation System - TipRanks
Adagio Medical (ADGM) files FDA PMA for vCLAS ventricular tachycardia ablation system - Stock Titan
Adagio Medical submits FDA application for VT ablation system By Investing.com - Investing.com Nigeria
Adagio Medical submits FDA application for ventricular tachycardia ablation system - Medical Economics
Adagio Medical submits FDA application for VT ablation system - Investing.com
Adagio Medical submits premarket approval application to FDA for Vclas® ventricular ablation system - marketscreener.com
First purpose-built VT ablation system heads to FDA after 84% shock-free trial - Stock Titan
Adagio Medical Holdings' US$2.5m Market Cap Fall Books Insider Losses - Sahm
Perceptive Advisors (NASDAQ: ADGM) discloses 55.4% stake via Schedule 13G/A - Stock Titan
Adagio Medical Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
TradingKey - TradingKey
ADGM Stock Price, Quote & Chart | ADAGIO MEDICAL HOLDINGS INC (NASDAQ:ADGM) - ChartMill
Adagio Medical : BofA Securities 2026 Health Care Conference Presentation (9e4df6) - marketscreener.com
Adage Capital (ADGM) reports 1,258,501 shares, 5.67% stake - Stock Titan
Adagio Medical Holdings Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Adagio Medical Holdings, Inc. Q1 2026 10-Q Report: Financials, Risk Factors, and Forward-Looking Statements - Minichart
Adagio Medical Reports Strong Q1 2026 Results and Breakthrough FULCRUM-VT Trial Data for Ultra-Low Temperature Ablation Technology 1 - Minichart
Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress - BioSpace
Adagio Medical Holdings, Inc. 1Q 2026: Revenue $5.2M, EPS ($0.31) — 10-Q Summary - TradingView
Adagio Medical (NASDAQ: ADGM) Q1 2026 loss, cash burn and going concern warning - Stock Titan
Adagio Medical (NASDAQ: ADGM) posts Q1 2026 loss, highlights -VT trial and PMA plans - Stock Titan
Adagio Medical Holdings Inc (ADGM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Adagio Medical Holdings (ADGM) price target decreased by 12.50% to 3.57 - MSN
Adagio Medical (ADGM) outlines 2026 director elections and auditor vote - Stock Titan
ADGM - Finviz
Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference - BioSpace
Adagio Medical heart ablation system shows 84% freedom from shock - MSN
12 Health Care Stocks Moving In Monday's After-Market SessionAdagio Medical Holdings (NASDAQ:ADGM), Ad - Benzinga
Midday Stock Roundup: Willdan Group Drops 14% - Orange County Business Journal
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Adagio Medical’s vCLAS System Achieves 84% Freedom From Shock in Pivotal FULCRUM-VT Trial for Ventricular Tachycardia 1 - Minichart
Lake Street Maintains Adagio Medical(ADGM.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Why Is Adagio Medical Stock Gaining Monday?Adagio Medical Holdings (NASDAQ:ADGM) - Benzinga
Adagio Medical reports positive six-month results in FULCRUM-VT trial - Yahoo Finance
Adagio Medical Posts Strong Pivotal Results for VT Ablation - TipRanks
Adagio Medical (ADGM) reports strong pivotal -VT results for vCLAS VT ablation - Stock Titan
Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System - BioSpace
Adagio Medical secures FDA clearance to broaden ventricular ablation study - MSN
Adagio Medical announces positive pivotal results for vCLAS ventricular ablation system - marketscreener.com
ADGM SEC FilingsAdagio Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Adagio Med (ADGM) Future Outlook | Q4 2025: EPS Exceeds ExpectationsBalance Sheet - Cổng thông tin điện tử tỉnh Tây Ninh
Adagio Med (ADGM) Stock: Technical Outlook (Weakens) 2026-04-22Reversal Picks - Cổng thông tin điện tử tỉnh Lào Cai
Adagio Medical Holdings schedules annual meeting for June 16, sets proposal deadlines - Investing.com
Adagio Medical Sets 2026 Annual Meeting, Proposal Deadlines - TipRanks
Adagio Medical (NASDAQ: ADGM) sets 2026 meeting date and April 30 proposal deadline - Stock Titan
Adagio Med (ADGM) Stock: Why Capex Plans (Underperforming) 2026-04-20Buy Signals - Xã Thanh Hà
Adagio Medical Holdings Inc Stock (ADGM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Adagio Medical Holdings Inc Stock (ADGM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Usen Todd | Chief Executive Officer |
Dec 12 '25 |
Buy |
1.09 |
207,315 |
225,973 |
207,315 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):